National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, 20892, United States
NCT Number: NCT00025987
This study will evaluate the effectiveness of a specially designed head-neck cooling system for way lowering the body's central, or core, temperature and cooling the brain. Brain cooling has an effect on stopping seizure discharges in the brain as well as the seizures themselves. If this system works to cool the brain, a similar study may be tried in patients with epilepsy.
Normal volunteers 21 years of age and older who have no medical or neurological condition and do not use any medications may be eligible for this study. Candidates will be screened with an interview. Women will have a pregnancy test. Those enrolled will be hospitalized twice for overnight stays, with the admissions 2 to 3 days apart.
Participants will have a medical history, physical and neurological examinations, electroencephalogram (EEG) and electrocardiogram (EKG). Then, electrodes will be attached to their scalp, forearm and calf to measure temperatures in those locations. Intestinal (core) temperature will be measured with a temperature-sensing pill, which will be swallowed earlier), and a hand-held infrared thermometer will be used to measure temperatures from the ear canal, face, head, arms legs, and abdomen. Electrodes on the scalp will also measure changes in blood volume in the brain for a study of brain blood flow. Subjects will be seated in a comfortable chair and fitted with the cooling system, a portable unit with a circulating coolant. Cooling will last 30 minutes for the first session and 60 minutes for the second. Participants will be monitored for at least 30 minutes after each session to track temperature changes and have a post-cooling EEG recording.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 1
Bethesda, Maryland, 20892, United States
The aim of this protocol is to study thermal responses in normal volunteers using a special cooling system designed to cool the head and neck. Temperature will be monitored at various locations including the scalp, face, mouth, ears (tympanic), arms, legs, and rectum. Previous studies indicate that cooling of the brain can be achieved with the head-neck cooling method. We hope to derive cooling parameters that will be used in a future study involving patients with epilepsy.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
21 years and older
No neurological or medical condition
No use medication of any kind, including prescription, over-the-counter or herbal medicines.
No history of any kind of gastrointestinal tract disorders
Exclusion criteria
Women who are pregnant (screened with urine pregnancy test)
Those with progressive neurological disorders
Those sensitive to coldness
Those taking medication
Those who smoke
Those whose heart rate less than 50 or more than 100
Those who are less than 80 pounds or excessively overweight
Those who have a history of gastrointestinal disorders (i.e. diverticulitis and other inflammatory bowel diseases)
Those who have difficulty swallowing or whose gag reflex is impaired
National Institute of Neurological Disorders and Stroke (NINDS)
Nih
Thermal Responses In Normal Volunteers To Head-Neck Cooling
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07689084
Brain Diseases, Central Nervous System Diseases
Marburg, Hesse, Germany
View Trial DetailsNCT06847152
Brain Diseases, Central Nervous System Diseases
Chambéry, Savoie, France
View Trial DetailsNCT05171725
Alzheimer Disease, Brain Diseases
Athens, Greece
View Trial DetailsNCT04266041
Behavior, Brain Diseases
Lebanon, New Hampshire, United States
View Trial Details